Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.
Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for inner ear disorders.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Avava is a Pioneer precision skin therapy to improve the quality of life for patients around the world.
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy with comfort.
Perceive Pharma operates as a pharmaceutical company.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Somethings is a platform for wellness tailored to young people that links youngsters with qualified mentors.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.
OSPRI is updating the infectious illness testing plan.
Amalgam Rx develops and distributes digital health products that support patients and healthcare providers in decision-making.
Catalio Capital Management has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Life Science. The firm invests across 27 different industry categories.
Among tracked funding rounds, Dianthus Therapeutics received $719.0M in a Post-IPO Equity round. Catalio Capital Management's total known invested capital is $12.7B.
Catalio Capital Management's average investment size is $93.1M across its portfolio of 132 companies.
Recent Catalio Capital Management portfolio additions include Beacon Biosignals, Pheast Therapeutics, Neumora Therapeutics, Spiral Therapeutics, Satellite Bio. These companies were founded in 2020 or later.